Selective Serotonin Reuptake Inhibitors (SSRIs) are types of antidepressants. Brand names of SSRIs include: Paxil, Zoloft, Celexa, Prozac, Lexapro, Symbyax, Wellbutrin and Effexor. These drugs inhibit neuronal serotonin and norepinephrine reuptake and slightly inhibit dopamine reuptake. SSRIs have been associated with serious, life-threatening birth defects. Research suggests that, if a mother took SSRI’s during pregnancy, […]
Did you buy Diamond Walnuts, believing the statements on the package meant the Omega-3 fatty acid content of walnuts is related to a reduction in coronary heart disease? If so, you were misled.
On February 22, 2010, the Food & Drug Administration (FDA) issued a warning letter to Diamond Foods, Inc. about its “Diamond of California Shelled Walnuts.” The FDA found that packaging for the product makes an “unauthorized health claim,” in violation of FDA regulations. Specifically, the FDA found that the Diamond Walnuts packaging label’s representation about the “Omega-3 fatty acid” content in walnuts makes it seem as if it was related to a reduction in coronary heart disease (CHD). The FDA concluded “[t]here is not sufficient evidence to identify a biologically active substance in walnuts that reduces the risks of CHD.” The FDA also found some other Omega-3 fatty acid claims on Diamond Walnut’s website made it illegal to market the product. Diamond Walnuts FDA Ltr
We are attorneys investigating the possibility of bringing a potential class action lawsuit for consumers who purchased Diamond Walnuts. To find out if you have a potential claim against Diamond Walnuts or to be part of any class action we may file, please contact us for a free consultation at 1-800-642-5297, or by submitting the contact form below: